Ex-Dividend Reminder: CONMED, Community Trust Bancorp and RenaissanceRe Holdings

CONMED Corp (CNMD), Community Trust Bancorp (CTBI), and RenaissanceRe Holdings (RNR) are scheduled to trade ex-dividend on September 15, 2025, for their upcoming quarterly payouts. CNMD's $0.20 dividend is expected to result in a 0.38% price adjustment, CTBI's $0.53 a 0.92% adjustment, and RNR's $0.40 a 0.17% adjustment, all else being equal. These dividends translate to estimated annualized yields of 1.51% for CNMD, 3.69% for CTBI, and 0.67% for RNR, with historical dividend stability noted as a key factor for investor due diligence.

Analysis

CONMED Corp. (CNMD), Community Trust Bancorp (CTBI), and RenaissanceRe Holdings (RNR) will trade ex-dividend on September 15, 2025, triggering an expected mechanical price drop in their shares. The declared quarterly dividends of $0.20 for CNMD, $0.53 for CTBI, and $0.40 for RNR correspond to anticipated single-day price adjustments of -0.38%, -0.92%, and -0.17% respectively, all else being equal. When annualized, these payouts translate to significantly different yields: CTBI offers the most substantial estimated yield at 3.69%, while CNMD provides a moderate 1.51% and RNR a lower 0.67%. This highlights CTBI as the more attractive option from a pure income perspective among the three. Notably, on the day of this announcement, CNMD shares were down approximately 2.2%, a decline that substantially exceeds the expected dividend adjustment and indicates potential underlying selling pressure. In contrast, CTBI and RNR shares traded with minimal volatility, suggesting their price movements were not materially impacted by factors beyond the routine dividend announcement.

Key Decisions for Investors

• Investors seeking to capture the dividend must own the shares before the September 15, 2025 ex-dividend date, while being mindful of the corresponding price drop that will occur at the market open.
• For income-focused portfolios, Community Trust Bancorp's (CTBI) estimated annualized yield of 3.69% is significantly more compelling than that of CNMD (1.51%) or RNR (0.67%), warranting a closer look at its dividend history for stability.
• The 2.2% decline in CONMED Corp (CNMD) shares, which far outpaces the 0.38% expected dividend impact, suggests negative sentiment or fundamental weakness that requires investigation beyond the scope of this dividend event.